Hinge Health (NYSE:HNGE) Stock Price Down 7.2% - Here's What Happened

Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s share price traded down 7.2% during mid-day trading on Tuesday . The stock traded as low as $47.50 and last traded at $48.00. 405,293 shares were traded during trading, a decline of 60% from the average session volume of 1,003,299 shares. The stock had previously closed at $51.75.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Hinge Health to a "hold" rating in a report on Monday, June 2nd. Needham & Company LLC assumed coverage on Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $47.00 price objective for the company. William Blair began coverage on Hinge Health in a research note on Monday, June 16th. They issued an "outperform" rating on the stock. Royal Bank Of Canada assumed coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $45.00 price objective for the company. Finally, Bank of America started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $42.00 target price on the stock. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Hinge Health has an average rating of "Moderate Buy" and a consensus price target of $46.00.

Hinge Health Price Performance

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.